Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …
South Africa
CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes
Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …
CND Thematic Discussions // Session 8 – High transmission of HIV, HCV and other blood-borne diseases associated with drug use
Presenter 1, UNODC: Thank you, Mr. Chair, excellencies, ladies, and gentlemen. I will briefly discuss the lessons learned in the actual UNODC Partnership Project addressing drug use issues in Afghanistan amid the continuing humanitarian crisis. The project received funding support from the European Union for the implementation period 2023 to 2026. Addressing existing fragilities, including …
CND Thematic Discussions / Session 7 – Increase in drug-related deaths – unmet need for drug treatment and health services
Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …
CND Thematic Discussions // Session 6 – Non-compliance of responses with international drug control conventions & human rights obligations
Chair: Welcome back. The challenge that we will be focusing on this afternoon responses not in conformity with the three international drug conventions, and not in conformity with applicable international human rights obligations pose a challenge to the implementation of joint commitment based on the principle of responsibility. UNODC Scientific Services Branch: I have a brief moment …
Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND
Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …